Login / Signup

Rational targeting Cdc42 restrains Th2 cell differentiation and prevents allergic airway inflammation.

Jun-Qi YangKhalid W KalimYuan LiXin DuanPhuong NguyenGurjit K Khurana HersheyJohn KronerBrandy RuffLi ZhangNathan SalomonisMark RochmanTing WenYi ZhengFukun Guo
Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2018)
Cdc42 is required for Th2 cell differentiation and allergic airway inflammation, and rational targeting Cdc42 may serve as a preventive but not therapeutic approach for asthma control.
Keyphrases
  • allergic rhinitis
  • cell cycle
  • cancer therapy
  • chronic obstructive pulmonary disease
  • cell proliferation
  • cystic fibrosis